KINOMICA
LIVE

Serial Number

88272871

Owner

Kinomica Limited

Attorney

Andrew D. Price

Filing Date

Jan 23, 2019

Add to watchlist:

No watchlists yet
View on USPTO

KINOMICA Trademark

Serial Number: 88272871 • Registration: 6150426

KINOMICA is a trademark filed by Kinomica Limited on January 23, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

Kinomica Limited (4 trademarks)

Room E204 Queen's Building
London E14NS , GB

Entity Type: 98

Trademark Details

Filing Date

January 23, 2019

Registration Date

September 15, 2020

Published for Opposition

June 30, 2020

Goods & Services

Scientific instruments and equipment, namely, scientific equipment in the nature of mass spectrometers and liquid chromatography equipment, namely, chromatography columns for laboratory use for measuring and analyzing proteins, enzymes, genes and tumors; downloadable databases in the field of proteins, enzymes, genes, tumors, bioinformatics and drug efficacy; downloadable software for scientific, medical, healthcare, pharmaceutical and biotechnology analysis, namely, software for the identification, cataloguing, characterizing and analysis of data relating to proteins, enzymes, genes, tumors, bioinformatics and drug efficacy

Scientific instruments and equipment, namely, medical diagnostic assays for measuring and analyzing proteins, enzymes, genes and tumors

Licensing of intellectual property

Scientific instruments and equipment, namely, diagnostic assays for measuring and analyzing proteins, enzymes, genes and tumors other than for medical or veterinary use

Medical services; healthcare services; medical screening; medical diagnostic services; providing an online, searchable database featuring data relating to the identification, cataloguing, characterizing and analysis of proteins, enzymes, genes, tumors, bioinformatics and drug efficacy; tumor testing and profiling, namely, tumor DNA sequencing and analysis for medical diagnostic purposes; gene expression profiling for medical diagnostic purposes; sequencing DNA for medical diagnostic purposes; tumor testing and profiling, namely, medical testing in the field of tumor identification, analysis and treatment; tumor testing and profiling, namely, diagnostic testing in the field of tumor treatment; gene expression profiling for medical diagnostic analysis purposes; sequencing DNA for medical diagnostic analysis purposes; providing an online, searchable database featuring patient data used in the treatment of individuals relating to the identification, cataloguing, characterizing and analysis of proteins, enzymes, genes, tumors, bioinformatics and drug efficacy

Scientific and technological services and research and design relating thereto, namely, research services in the field of protein, enzyme, gene and tumor analysis, design of research programmes and studies relating to protein, enzyme, gene and tumor analysis; medical research; medical development, namely, medicine development services; pharmaceutical and biotechnology research and development; design and development of computer software; providing temporary use of online, non-downloadable software for the identification, cataloguing, characterizing and analysis of data relating to proteins, enzymes, genes, tumors, bioinformatics and drug efficacy; proteomics, namely, medical and scientific research in the field of proteomes; kinase profiling and screening in the nature of testing of enzymes for scientific and medical research purposes; biomarker profiling and screening in the nature of testing of naturally occurring molecules, genes, or characteristics in the human body for scientific and medical research purposes; tumor testing and profiling, namely, diagnostic tests in the field of tumor identification and analysis for medical research purposes; gene expression profiling and analysis for medical research purposes; sequencing DNA and analysis for medical research purposes; genotyping for medical research and analysis purposes; contract scientific, medical, pharmaceutical and biotechnology research and laboratory services; providing an online, searchable database featuring medical research data relating to the identification, cataloguing, characterizing and analysis of proteins, enzymes, genes, tumors, bioinformatics and drug efficacy; providing temporary use of online, non-downloadable software for scientific, medical, healthcare, pharmaceutical and biotechnology analysis, namely, software for the identification, cataloguing, characterizing and analysis of data relating to proteins, enzymes, genes, tumors, bioinformatics and drug efficacy

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Sep 15, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Sep 15, 2020 R.PR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 20, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 20, 2020 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 20, 2020 COAR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 30, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 30, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 10, 2020 NONP
EXPARTE APPEAL TERMINATED
May 23, 2020 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
May 20, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 20, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
May 20, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 20, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2020 CRFA
ASSIGNED TO LIE
May 13, 2020 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 10, 2020 ERFR
EX PARTE APPEAL-INSTITUTED
May 10, 2020 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
May 10, 2020 JURT
EXPARTE APPEAL RECEIVED AT TTAB
May 10, 2020 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 13, 2019 GNFN
FINAL REFUSAL E-MAILED
Nov 13, 2019 GNFR
FINAL REFUSAL WRITTEN
Nov 13, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 18, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 18, 2019 CRFA
ASSIGNED TO LIE
Oct 11, 2019 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Oct 7, 2019 PARI
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 7, 2019 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 5, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 4, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 5, 2019 GNRN
NON-FINAL ACTION E-MAILED
Apr 5, 2019 GNRT
NON-FINAL ACTION WRITTEN
Apr 5, 2019 CNRT
ASSIGNED TO EXAMINER
Apr 4, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 14, 2019 NWOS
NEW APPLICATION ENTERED
Jan 26, 2019 NWAP